Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Down 32.5% in November

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 15,400 shares, a decrease of 32.5% from the October 31st total of 22,800 shares. Based on an average trading volume of 6,300 shares, the short-interest ratio is presently 2.4 days.

Cardio Diagnostics Price Performance

Shares of NASDAQ:CDIOW traded down $0.01 during trading on Friday, reaching $0.03. 157 shares of the company’s stock traded hands, compared to its average volume of 14,558. The company has a 50-day simple moving average of $0.03 and a 200-day simple moving average of $0.04. Cardio Diagnostics has a fifty-two week low of $0.02 and a fifty-two week high of $0.28.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.